Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Forbion Growth Opportunities Fund III Cooperatief U.A. reported direct ownership of 11,640,546 shares of Braveheart Bio, Inc. (BRVE), approximately 12.9%; Forbion Ventures Fund VII Cooperatief U.A. reported direct ownership of 10,185,478 shares, approximately 11.3%. Their respective management companies may be deemed to have voting and investment power over the shares held by their associated funds, so those positions are not additional share blocks. The percentages are based on 90,038,969 common shares outstanding as of September 3, 2026.
Key Figures
Shares beneficially owned:11,640,546 sharesOwnership percentage:12.9%Shares beneficially owned:10,185,478 shares+2 more
5 metrics
Shares beneficially owned11,640,546 sharesDirectly owned by Forbion Growth Opportunities Fund III Cooperatief U.A.
Ownership percentage12.9%Forbion Growth Opportunities Fund III Cooperatief U.A.; based on shares outstanding as of September 3, 2026.
Shares beneficially owned10,185,478 sharesDirectly owned by Forbion Ventures Fund VII Cooperatief U.A.
Ownership percentage11.3%Forbion Ventures Fund VII Cooperatief U.A.; based on shares outstanding as of September 3, 2026.
Common shares outstanding90,038,969 sharesAs of September 3, 2026, as reported by Braveheart Bio.
Key Terms
beneficially owned, Shared Voting Power, Shared Dispositive Power
3 terms
beneficially ownedregulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Powerregulatory
"Shared Voting Power 11,640,546.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 11,640,546.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many BRVE shares do the Forbion funds own?
Forbion Growth Opportunities Fund III Cooperatief U.A. reported direct ownership of 11,640,546 BRVE common shares, approximately 12.9%, and Forbion Ventures Fund VII Cooperatief U.A. reported direct ownership of 10,185,478 shares, approximately 11.3%. Their respective management companies may be deemed to share voting and investment power over the same fund-held shares; those manager-reported positions are not additional blocks.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Braveheart Bio, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
10567X101
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
10567X101
1
Names of Reporting Persons
Forbion Growth Opportunities Fund III Cooperatief U.A.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NETHERLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,640,546.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,640,546.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,640,546.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
12.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
10567X101
1
Names of Reporting Persons
Forbion Growth III Management B.V.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NETHERLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,640,546.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,640,546.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,640,546.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
12.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
10567X101
1
Names of Reporting Persons
Forbion Ventures Fund VII Cooperatief U.A.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NETHERLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,185,478.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,185,478.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,185,478.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
11.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
10567X101
1
Names of Reporting Persons
Forbion Ventures VII Management B.V.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NETHERLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,185,478.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,185,478.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,185,478.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
11.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Braveheart Bio, Inc.
(b)
Address of issuer's principal executive offices:
One Letterman Drive, Building A, Suite A4-300, San Francisco, CA 94129
Item 2.
(a)
Name of person filing:
This statement is being filed by Forbion Growth Opportunities Fund III Cooperatief U.A. ("Forbion Growth III COOP"), Forbion Growth III Management B.V. ("Forbion Growth III"), Forbion Ventures Fund VII Cooperatief U.A ("Forbion VII COOP") and Forbion Ventures VII Management B.V. ("Forbion VII"). The foregoing are sometimes referred to collectively as the "Reporting Persons".
(b)
Address or principal business office or, if none, residence:
The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands.
(c)
Citizenship:
Each of the Reporting Persons is organized under the laws of the Netherlands.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP Number(s):
10567X101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Forbion Growth III COOP directly owns 11,640,546 shares of Common Stock of the Issuer, which represents approximately 12.9% of the outstanding Common Stock. Forbion VII COOP directly owns 10,185,478 shares of Common Stock of the Issuer, which represents approximately 11.3% of the outstanding Common Stock. Forbion Growth III, as the director of Forbion Growth III COOP, may be deemed to have voting and investment power over the shares held directly by Forbion Growth III COOP. Forbion VII, as the director of Forbion VII COOP, may be deemed to have voting and investment power over the shares held directly by Forbion VII COOP.
(b)
Percent of class:
See Item 4(a). The percent of class is based upon 90,038,969 shares of Common Stock outstanding as of September 3, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on September 8, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
Forbion Growth III COOP - 11,640,546
Forbon Growth III - 11,640,546
Forbion VII COOP - 10,185,478
Forbion VII - 10,185,478
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
Forbion Growth III COOP - 11,640,546
Forbon Growth III - 11,640,546
Forbion VII COOP - 10,185,478
Forbion VII - 10,185,478
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Forbion Growth Opportunities Fund III Cooperatief U.A.